Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is based on data from the LIBERTY-CUPID clinical study program …